AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

1 Hour Education Modules

Our 1 hour Education Modules cover a range of therapeutic areas and are quick and easy to complete anytime, anywhere. You will receive a certificate for completing any of these education activities. CatCPD points are also available.

Continuous glucose monitoring and flash glucose monitoring in type 2 diabetes

Continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) are new technologies that can assist in achieving effective glycaemic control in type 2 diabetes. This module explores the role of CGM and Flash GM in providing effective diabetes care, and provides guidance on interpreting glucose profiles and setting personalised targets.

Dementia in diverse groups - On-demand webinar

As in many therapeutic areas, cultural and linguistic diversity has an impact on the recognition, diagnosis and management of dementia -- but the ‘how’, ‘why’ and ‘what to do’ for people with dementia in diverse groups can be tricky to navigate in busy primary practice. This activity explores the different clinical presentations of dementia in diverse populations, as well as the social, family and other considerations relevant to people in cultural and linguistically diverse (CALD) groups.

Managing epilepsy in older people: Optimising outcomes in general practice

Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Pages